“Gastrointestinal Therapeutics market set to grow to $68bn by 2028” says new Visiongain report

04 October 2019
Pharma

Visiongain has published a new pharma report Top 50 Gastrointestinal Therapeutic Companies 2020: GlaxoSmithKline, Abbott, Allergan, Eli Lilly, Evoke Pharma, Other Companies.

The gastrointestinal (GI) therapeutics industry is on the rise; growing to reach $68,237.0m by 2028. This growth stems from rising prevalence of GI disorders. Moreover, the increase in R&D has been a priority of the big pharma companies to infuse the drug pipelines with a new set of candidates with a high potential of reaching the clinical stage. However, the pricing pressure due to rising competition has hampered the market growth. On the contrary, the expiry of high-profile patents, which will carve the path for the launch of generic drugs in the market can provide growth opportunities to the other players in the market.

This report profiled the selected companies: Abbott, AbbVie, Alexion Pharmaceuticals, Allergan, ANI Pharmaceuticals, Inc., AstraZeneca, Bayer AG, Biogen, Eisai Co., Ltd., Eli Lilly, Evoke Pharma, GlaxoSmithKline and other companies.

The lead analyst commented that "Emerging economies of Asia-Pacific and LAMEA possess high potential for gastrointestinal drugs. The rise in purchasing power in these economies is expected to augment the market growth. Rise in awareness regarding GI diseases such as, ulcerative colitis, IBD and cancer and the use of novel drugs the treatment of these diseases in the developing regions, have resulted in regulatory authorities in these regions to take key decisions to improve the legislations of gastrointestinal drugs."

Notes for Editors
f you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Pharmaceutical Contract Manufacturing market set to grow to $138bn by 2024” says Visiongain report

In recent years, one area of biopharmaceutical manufacturing that has come under increasing interest is ADC manufacturing.

16 January 2020

Read

New Advances in the Wound Care Market

In recent years, with the advent of technology, medical practitioners and manufacturers have made huge strides in the wound care market. As one of today’s leading market research and report firms, Visiongain is committed to providing you the most up-to-date information about this exciting industry. That’s why below we’ve collected some of today’s latest products and technologies for your perusal.  …

14 January 2020

Read

Recent Highs & Lows in the Vaccine Market 

With the emergence of new health technology and advances in vaccines, manufacturers and key stakeholders can position themselves to generate big returns in the coming years. However, getting ahead of the competition will require having the right tools at your disposal, which is why Visiongain is proud to offer extensive vaccine market forecasts, as well as reports from other verticals …

14 January 2020

Read

Current Developments in the Global Dermatology Market Pipeline

New trials from around the world are affecting the global dermatology market on an almost daily basis, providing patients with new drugs and medical practitioners with more innovative treatment technology than ever before. That’s why Visiongain has made it their business to help inform key stakeholders and business owners about the most current changes and emerging trends.  Here are a …

14 January 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever